
Biosense Technologies Private
Biosense | Health * Technology * People.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | N/A | Debt | |
Total Funding | 000k |
Related Content
Biosense is a healthcare technology company focused on providing innovative diagnostic solutions for diabetes, anemia, and malnutrition. Operating primarily in the Indian market, Biosense addresses the critical healthcare needs of a population burdened with these conditions. The company serves a wide range of clients, including individual patients, healthcare providers, and medical institutions.
Biosense's product portfolio includes devices like the SYNC Glucometer for blood glucose monitoring, Uchek for urinalysis, and ToucHb for anemia screening. These products are designed to offer accurate, reliable, and easy-to-use diagnostic tools that can be used both in clinical settings and at home.
The business model is centered around the sale of these diagnostic devices and their consumables, such as glucometer strips and test kits. Revenue is generated through direct sales to consumers, partnerships with healthcare providers, and collaborations with medical institutions.
By leveraging advanced technology, Biosense aims to make healthcare more accessible and affordable, contributing to better disease management and improved health outcomes.
Keywords: diagnostic solutions, diabetes, anemia, malnutrition, healthcare technology, SYNC Glucometer, Uchek, ToucHb, India, medical devices.